$55.61
-0.460 (-0.82%)
At Close: Jun 02, 2026
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations
09:00am, Monday, 01'st Jun 2026
As theranostics adoption acceleratesi and radiopharmaceutical demand grows,ii healthcare systems are under increasing pressure to scale nuclear medicine operat
Dolby and rednote Bring More Immersive Storytelling to Video Content with Dolby Atmos
08:30am, Friday, 29'th May 2026
/PRNewswire/ -- Dolby Laboratories (NYSE: DLB), a leader in immersive entertainment, and rednote, the leading lifestyle interest community, today announced
Dolby Recognized as 2025 Supplier of the Year and Overdrive Award Winner by General Motors
09:00am, Wednesday, 20'th May 2026
SAN FRANCISCO, May 20, 2026 /PRNewswire/ -- Dolby Laboratories (NYSE: DLB), a leader in immersive entertainment, has earned two of the automotive industry's most prestigious supplier honors from Gen
Dolby Laboratories to Present at Upcoming Investor Conferences
04:15pm, Tuesday, 19'th May 2026
SAN FRANCISCO, May 19, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced that management will present at the following investor conferences: Kevin Yeaman, President and CEO, wil
SONY's Q4 Earnings Plunge Y/Y Despite Healthy Revenues, G&NS Weakens
11:20am, Friday, 08'th May 2026
Sony Q4 FY2025 revenues jump 8% to 3,036.4B yen, but GAAP EPS fall to 13.93 yen as gaming and "All Other" weighed on results.
Dolby: I Don't Mind Waiting In 2026
05:51am, Sunday, 03'rd May 2026
Dolby Labs is rated a 'BUY' with a conservative $80/share price target, reflecting 17–25% annualized upside potential through 2028. DLB trades at a rare sub-15x P/E, supported by robust patent-drive
Why Dolby Labs Stock Crashed Today
10:00am, Friday, 01'st May 2026
Dolby stock is getting static over its Q3 earnings guidance.
Dolby Q2 Earnings Top Estimates on Licensing Strength, Revenues Up Y/Y
09:05am, Friday, 01'st May 2026
DLB beats Q2 estimates as licensing growth, strong broadcast demand and expanding Dolby Atmos adoption drive revenue and a steady outlook.
Dolby Laboratories, Inc. (DLB) Q2 2026 Earnings Call Transcript
01:01am, Friday, 01'st May 2026
Dolby Laboratories, Inc. (DLB) Q2 2026 Earnings Call Transcript
Compared to Estimates, Dolby Laboratories (DLB) Q2 Earnings: A Look at Key Metrics
08:00pm, Thursday, 30'th Apr 2026
The headline numbers for Dolby Laboratories (DLB) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Stree
Dolby Laboratories (DLB) Q2 Earnings and Revenues Top Estimates
07:26pm, Thursday, 30'th Apr 2026
Dolby Laboratories (DLB) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.31 per share. This compares to earnings of $1.34 per share a year ago.
Dolby Laboratories Reports Second Quarter 2026 Financial Results
04:15pm, Thursday, 30'th Apr 2026
SAN FRANCISCO, April 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB) today announced the company's financial results for the second quarter of fiscal 2026. "We continue to strengthen our
Dolby Laboratories (NYSE:DLB) Receives Average Rating of “Moderate Buy” from Analysts
02:28am, Sunday, 19'th Apr 2026
Dolby Laboratories (NYSE: DLB - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five brokerages that are covering the firm, MarketBeat Ratings reports. Two investment
Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2026 Financial Results
04:15pm, Wednesday, 08'th Apr 2026
SAN FRANCISCO, April 8, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal ye
Dolby Labs Has Easy 30% Upside
10:21am, Monday, 06'th Apr 2026
Dolby Laboratories (DLB) offers a compelling risk-reward profile with high margins, robust free cash flow, and a reasonable valuation. DLB's intrinsic value is estimated near $80 per share, implying 3
Sign In
Buy DLB